title: Intracoronary transplantation of genetically modified mesenchymal stem cells, a novel method to close muscular ventricular septal defects.
abstract: Muscular ventricular septal defects remain a challenge despite the progress in surgical and interventional closure of ventricular septal defects. Our hypothesis was inspired by the fact that more than two thirds of children with muscular ventricular septal defects experienced spontaneous closure. Therefore, we intend to induce the spontaneous closure of muscular ventricular septal defects by means of targeted intracoronary injection of mesenchymal stem cells which are genetically modified to enhance myocardial hypertrophy. The transplantation of bone marrow derived cells has been observed to be effective in improving tissue recovery and ameliorating cardiac function in patients and animal models with ischemic heart disease, acute myocarditis and dilated cardiomyopathy. We expect that the targeted intracoronary transplantation of genetically modified mesenchymal stem cells could enhance the tissue generation and myocardial hypertrophy simultaneously, which may lead to the closure of muscular ventricular septal defects in a way that imitate the spontaneous closure of ventricular septal defects.
authors.affiliation: Department of Cardiology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
authors.forename: Qing
authors.initials: Q
authors.lastname: Yang
authors.forename: Juqian
authors.initials: J
authors.lastname: Zhang
authors.forename: Jian
authors.initials: J
authors.lastname: Jiang
mesh_terms: D006345:Heart Septal Defects, Ventricular / Q000601:surgery / Q000628:therapy*; D006801:Humans; D045164:Mesenchymal Stem Cell Transplantation